Robert S. Lee, MD

Dr. Robert S. Lee joined Los Alamitos Cardiovascular in 2013 and became a partner in July 2015. Dr. Lee is board certified in Cardiovascular Disease, Interventional Cardiology, Nuclear Cardiology, Echocardiography and Internal Medicine.

Dr. Robert S. LeeAnyone who’s been a patient, or has had a loved one be a patient, knows what it's like to worry about health. We can quickly realize that it truly is the most important thing, and it’s that responsibility that made me want to become a doctor...

On Medicine
I wake up every morning looking forward to going to work. It is an absolute privilege to build relationships with patients and help them feel better so that they can enjoy their lives.

On Los Alamitos Cardiovascular
What initially attracted me to Los Alamitos Cardiovascular was its reputation as a well-respected and established member of the community. I am thrilled to join a group of caring and skilled physicians, nurses and staff.

On My Specialty
Cardiologists have always challenged themselves to find better ways to treat people. It has become a field with so many remarkable medical and procedural therapies that have proven to not only help patients feel better, but also live longer.

Dr. Robert S. Lee's Curriculum Vitae

Printable VersionPrintable CV
Specialties: Cardiology, Nuclear Cardiology, Echocardiography and Interventional Cardiology
Board Certifications
and Licensure:
  • Certified in Interventional Cardiology
    American Board of Internal Medicine
    2013 (Expires 2023)
  • Certified in Cardiovascular Disease
    American Board of Internal Medicine
    2012 (Expires 2022)
  • Diplomate, Echocardiography
    National Board of Echocardiography

    2011 (Expires 2021)
  • Diplomate, Nuclear Cardiology
    Certification Board of Nuclear Cardiology

    2010 (Expires 2020)
  • Certified in Internal Medicine
    American Board of Internal Medicine
    2008 (Expires 2018)
  • Drug Enforcement Administration (DEA) Certificate
    2006 (Expires 2016)
  • California State Licensure
    Medical Board of California
    2006 (Expires 2016)
Foreign Languages:
  • Spanish and Korean
Committees: HARBOR-UCLA MEDICAL CENTER
  • Ad Hoc Committee for the Internal Review of the Pediatric Neonatal/Perinatal Training Program
    April 2009
  • Clinical Radiology Committee
    2008 – 2009
  • Utilization Review Committee
    2008 – 2009
  • Internal Medicine Quality Improvement Committee
    2008 – 2009
  • Intern Selection Committee
    2008 – 2009
Professional Societies:
  • American Society for Cardiovascular Angiography and Interventions (FSCAI)
    Member
  • American College of Cardiology (FACC)
    Member
  • American Heart Association (AHA)
    Member
Publications and
Presentations :
ARTICLES
  • Ahmadi N, Hajsadeghi F, Gul K, Leibfried M, DeMoss D, Lee R, Flores F, Nasir K, Hecht H, Naghavi M, Budoff MJ. Vascular Function Measured by Fingertip Thermal Reactivity is Impaired in Patients with Metabolic Syndrome and Diabetes Mellitus. Journal of Clinical Hypertension, November 2009; 11(11): 678-84.

  • Ibebuoju UN, Nasir K, Gopal A, Ahmadi N, Mao SS, Young E, Honoris L, Nuguri VK, Lee RS, Usman N, Rostami B, Pal R, Flores F, Budoff MJ. Comparison of Atherosclerotic Plaque Burden and Composition Between Diabetic and Non-diabetic Patients by Non-invasive CT Angiography. International Journal of Cardiovascular Imaging, October 2009; 25(7): 717-23.

  • Nagarakanti R, Sodhi S, Lee R, Ezekowitz M. Chronic Antithrombotic Therapy in Post- Myocardial Infarction Patients. Cardiology Clinics, May 2008; 26(2): 277-88.

  • Sodhi S, Lee R, Ezekowitz M. Chronic Antithrombotic Therapy in Post-Myocardial Infarction Patients. Clinics in Geriatric Medicine, February 2006; 22(1): 167-82.
ABSTRACTS
  • RS Lee, R Kaushal, T Bholat, KA Zhiroff, SC Jaquez, QT Bui, JL Thomas, WJ French. Patient Differences by Mode of Hospital Arrival for ST-Elevation Myocardial Infarction Treated with Primary PCI. Journal of the American College of Cardiology, November 2011; 58(20): B91.

  • Jug B, Papazian J, Lee R, Budoff MJ. Association of Lipoprotein Subfractions and Coronary Calcifications in Individuals at Intermediate Cardiovascular Risk. Journal of Cardiovascular Computed Tomography, June 2011; 5(4): S16.

  • Hajsadeghi F, Ahmadi N, Lee R, Sarlak B, Ramirez J, Flores F, Mao SS, Budoff MJ. Low Density Lipoprotein, High Density Lipoprotein and Lipoprotein (a) Subclasses and Their Relationship With Coronary Artery Calcification Is Asymptomatic Population. Journal of the American College of Cardiology, March 2008; 51(10): A150.

  • Ibebuogu UN, Nasir K, Gopal A, Ahmadi N, Mao SS, Young E, Honoris L, Nuguri VK, Lee R, Usman N, Rostami B, Pal R, Flores F, Budoff M. Comparison of Coronary Atherosclerotic Plaque Burden and Composition Between Diabetic and Nondiabetic Patients by Noninvasive CT Angiography. Arteriosclerosis, Thrombosis, and Vascular Biology, June 2008; 28(6): e134-e135.

  • Lee R, Hajsadeghi F, Ramirez R, Sarlak B, Gopal A, Ahmadi N, Budoff MJ. Insulin Resistance and Coronary Artery Calcification measured by Electron Beam Computed Tomography. Circulation, October 2007; 116(16): S611.

  • Budoff MJ, Lee R, Hajsadeghi F, Ahmadi N, Gopal A, Flores F. Homocysteine, Lipid Parameters, and Inflammatory Markers Relationship to Advanced Coronary Atherosclerosis on CT. Journal of Cardiovascular Computed Tomography, July 2007; 1(15): S9.

  • Budoff MJ, Gao YL, Child J, Carson S, Liu SL, Young E, Lee RS, Zemsky A, Shareghi S, Gopal A, Mao SS. A Comparison of Electron Beam Computed Tomography and 64-Channel Multislice Computed Tomography Scanner in Measuring Coronary Artery Calcium. Journal of Nuclear Cardiology, April 2007; 14(2): S92.

  • Seto TC, Barrett M, Bradley J, Lee R. Mastering Cardiac Auscultation over the Internet: Use of Computer-based Testing to Demonstrate the Power of Repetition. Chest, October 2004; 126(4): 880-881Sb.

  • Lee RS, Devereaux DC, Hamilton MA, Kobashigawa JA. Is Corticosteroid Weaning More Successful in Older Heart Transplant Patients? Journal of Investigative Medicine, January 2000; 48(1): 3A.

  • Kobashigawa JA, Takemoto S, Wener L, Tobis J, Lee R, Kumar N, Chuang JM, Moriguchi JD, Kawata N, Laks H. Development of Circulating, IgG Class I Antibodies is Associated with Increase in Intimal Thickness by Intravascular Ultrasound (IVUS) after Heart Transplant. The Journal of Heart and Lung Transplantation, January 2000; 19(1): 81-82.

  • Kobashigawa J, Kubak B, Camara R, Inglish J, Lee R, Moriguchi J, Hamilton M, Hage A, Kawata N, Laks H. Effective Cytomegalovirus Prophylaxis with Intravenous Followed by Oral Ganciclovir for Donor Positive/Recipient Negative Mismatch. Transplantation, April 15, 1999; 67(7): S102.

  • Lee RS, Ro TK, Hamilton MA, Kobashigawa JA. Treatment of Hypertension in Cardiac Transplant Recipients with Irbesartan. Journal of Investigative Medicine, February 1999; 47(2): 5A.

  • Kobashigawa JA, Ro TK, Moriguchi JD, Lee RS, Cassem JD, Hamilton MA, Hage A, Kawata N, Laks H. Hemodynamic Compromising Rejection is Associated with Increased Incidence of Transplant Coronary Artery Disease in Cardiac Transplant Recipients. The Journal of Heart and Lung Transplantation, January 1999; 18(1): 50.

  • Inglish JA, Hamilton MA, Lee RS, Kobashigawa JA. Effective Cytomegalovirus Prophylaxis with Intravenous Followed by Oral Ganciclovir. Journal of Investigative Medicine, March 1998; 46(3); 200A.
PRESENTATIONS
  • RS Lee, R Kaushal, T Bholat, KA Zhiroff, SC Jaquez, QT Bui, JL Thomas, WJ French. Patient Differences by Mode of Hospital Arrival for ST-Elevation Myocardial Infarction Treated with Primary PCI. Transcatheter Cardiovascular Therapeutics, San Francisco, CA, November 8, 2011.

  • Wallin D, Hunt D, Lee R. Adrenal Insufficiency: An Unusual Cause of Hypercalcemia. Solomon Scholars, University of California at Los Angeles, Los Angeles, CA, June 9, 2009.

  • Yan E, Lee, R, Swerdloff R. A Case of Elephantiasic Nodular Pretibial Myxedema? Solomon Scholars, University of California at Los Angeles, Los Angeles, CA, June 9, 2009.

  • Lee R, Hajsadeghi F, Ahmadi N, Gopal A, Flores F, Budoff M. Serum Inflammatory Markers and Coronary Artery Calcification. Solomon Scholars, University of California at Los Angeles, Los Angeles, CA, June 12, 2007.

  • Lee RS, Devereaux DC, Hamilton MA, Kobashigawa JA. Is Corticosteroid Weaning More Successful in Older Heart Transplant Patients? American Federation for Medical Research, Western Regional Meetings, Carmel, CA, February 9-12, 2000.

  • Lee RS, Ro TK, Hamilton MA, Kobashigawa JA. Treatment of Hypertension in Cardiac Transplant Recipients with Irbesartan. American Federation for Medical Research, Western Regional Meetings, Carmel, CA, January 27-30, 1999.
Education and Training:
  • Interventional Cardiology  Fellowship
    Harbor-UCLA Medical Center/Good Samaritan Hosptial
    Torrance, CA/Los Angeles, CA
    2012 – 2013

  • Chief Fellow, General Cardiology
    Harbor-UCLA Medical Center

    Torrance, CA
    2011 – 2012

  • General Cardiology Fellowship
    Harbor-UCLA Medical Center
    Torrance, CA
    2009 – 2012

  • Chief Resident, Internal Medicine
    Harbor-UCLA Medical Center
    Torrance, CA
    2008 – 2009

  • Residency, Internal Medicine
    Harbor-UCLA Medical Center
    Torrance, CA
    2006 – 2008

  • Internship, Internal Medicine
    Harbor-UCLA Medical Center
    Torrance, CA
    2005 – 2006

  • Medical Doctorate (MD)
    Drexel University, College of Medicine, Class of 2005

    Philadelphia, PA
    2001 – 2005

  • Certificate, Interdepartmental Medical Sciences Program
    Medical College of Pennsylvania, Hahnemann University

    Philadelphia, PA
    2000 – 2001

  • Bachelor of Science, Biochemistry
    Minor, Applied Developmental Psychology
    University of California Los Angeles, Class of 2000

    Los Angeles, CA
    1995 – 2000
Research Experience:
  • Barostim Therapy for Heart Failure (BeAT-HF): The Barostim Neo - Baroreflex Activation Therapy for Heart Failure is a prospective, randomized trial in subjects with reduced ejection fraction heart failure.
    Sub-Investigator | 2016 – Present
    Sponsor: CVRx, Inc.
    NCT02627196: https://clinicaltrials.gov/show/NCT02627196

  • MLHFQ Study: Evaluate and establish content validity of the Minnesota Living with Heart Failure Questionnaire (MLHFQ) in patients with Symptomatic Hypertrophic Cardiomyopathy.
    Sub-Investigator | 2016
    Sponsor: Gilead/ICON

  • THEMIS- A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus (THEMIS): A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Ticagrelor Twice Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Stroke in Patients With Type 2 Diabetes Mellitus (THEMIS - Effect of Ticagrelor on Health Outcomes in Diabetes Mellitus Patients Intervention Study).
    Sub-Investigator | 2015 – Present
    Sponsor: AstraZeneca
    NCT01991795: https://clinicaltrials.gov/show/NCT01991795

  • Retrospective Medical Records Review of Participants Interviewed for Study M-12347 (Concept Elicitation Focus Groups and Cognitive Interviews to Develop a New Patient Reported Outcome Instrument in Chronic Heart Failure).
    Sub-Investigator | 2015
    Sponsor: Amgen, Evidera

  • DECLARE-TIMI 58 Dapagliflozin Effect on CardiovascuLAR Events: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Dapagliflozin 10 mg Once Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patients with Type 2 Diabetes.
    Sub-Investigator | 2013 – Present
    Sponsor: AstraZeneca
    NCT01730534 | http://clinicaltrials.gov/ct2/show/NCT01730534

  • ODYSSEY EFC11570: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome
    Sub-Investigator | 2013 – Present
    Sponsor: Sanofi
    NCT01663402 | http://clinicaltrials.gov/ct2/show/NCT01663402

  • SILVER-AMI Risk Stratification in Older Persons with Acute Myocardial Infarction.
    Sub-Investigator | 2013 – 2017
    Sponsor: Yale University School of Medicine/NIH
    NCT01755052 | http://clinicaltrials.gov/ct2/show/NCT01755052

  • Cardiovascular Inflammation Reduction Trial (CIRT): Event Driven Trial of weekly Low-Dose Methotrexate in prevention of recurrent cardiovascular events among stable post myocardial infarction patients with Type II Diabetes or Metabolic Syndrome.
    Sub-Investigator | 2013– Present
    Sponsor: Center for Cardiovascular Disease Prevention Brigham and Women’s Hospital/National Heart Lung and Blood Institute
    NCT01594333 | http://clinicaltrials.gov/ct2/show/NCT01594333

  • The “BRIDGE” Trial (1U01HL08675501A1): Bridging Anticoagulation in Patients Who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive Procedure or Surgery.
    Sub-Investigator | 2013 – 2015
    Sponsor: National Institutes of Health (NIH)-National Heart, Lung and Blood Institute (NHLBI)
    NCT00786474 | http://clinicaltrials.gov/ct2/show/NCT00786474

  • GLORIA-AF 1160.129: Global Registry on Long-Term Oral Anti-thrombotic Treatment in Patients with Atrial Fibrillation Phase II-III.
    Sub-Investigator | 2013 – Present
    Sponsor: Boehringer Ingelheim
    NCT01468701 | http://clinicaltrials.gov/ct2/show/NCT01468701

  • ORBIT-AF I and II: Outcomes Registry for Better Informed Treatment of Atrial Fibrillation.
    Sub-Investigator | 2013 – Present
    Sponsor: Janssen Scientific Affairs, LLC
    Collaborator: Duke Clinical Research
    NCT01165710 | http://clinicaltrials.gov/ct2/show/NCT01165710
    NCT01701817 | http://clinicaltrials.gov/ct2/show/NCT01701817

  • ENGAGE: Phase III, randomized, double-blind, double-dummy, parallel group, multi-center, multi-national study for evaluation of efficacy and safety of DU-176b versus Warfarin in subjects with Atrial Fibrillation - Effective Anticoagulation with Xa next Generation in Atrial Fibrillation (ENGAGE - AF TIMI - 48).
    Sub-Investigator | 2013 – 2015
    Sponsor: Daiichi Sankyo Pharma Development
    NCT00781391 | http://clinicaltrials.gov/ct2/show/record/NCT00781391

  • Harbor-UCLA, Division of Cardiology: Clinical research involving the management and outcomes of patients with acute coronary syndromes in the cardiac catheterization laboratory, particularly patients with ST-elevation myocardial infarctions (STEMI).
    2010 – 2013
    Faculty Mentor: Dr. Joseph Thomas, Assistant Professor, Assistant Fellowship Program Director, Harbor-UCLA Medical Center

  • Harbor-UCLA, Division of Cardiology: Clinical research involving the utilization of computed tomography in the evaluation of various cardiovascular diseases.
    2007 – 2009
    Faculty Mentor: Dr. Matthew Budoff, Associate Professor, Fellowship Program Director and Director of Cardiac Computed Tomography, Harbor-UCLA Medical Center

  • UCLA Heart Transplant Program: Clinical research involving the medical care of cardiac transplant recipients.
    2007 – 2009
    Faculty Mentor: Dr. Jon Kobashigawa, Clinical Professor and Medical Director of the UCLA Heart Transplant Program